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The codes and practices of professional morality had
been enunciated centuries ago in the traditional Indian
systems of medicine. The modern code of medical and
research ethics has its origin in the Nuremberg Code,
Universal Declaration of Human Rights, Code of Medi-
cal Ethics by Medical Council of India, World Health
Assembly Helsinki Declaration, Belmont report and the
Revised Council for International Organizations of Med-
ical Sciences (CIOMS) guidelines. The revised Indian
Council of Medical Research (ICMR) guidelines have
been adopted in 2006.
The ethical principles of autonomy, justice, non-
maleficense and beneficense are applicable to any research
undertaken. Careful attention has to be given to the pro-
cesses of taking consent, assent from minors, re-consent,
community engagement, risk-benefit assessment, interven-
tions, data management and follow up. Special concerns
for cohorts include the difficulty in conveying results due
to the absence of immediate benefits and unpredictable
susceptibility due to genetic variations. There are issues of
confidentiality and stigmatization due to the allotment of
unique identification. There is a need for translational
research in cohort studies to understand the priorities,
validity and applicability in different cultural settings and
the role of community based participatory research. There
are concerns in research methodology due to shifting from
acute paradigm to chronic paradigm, involvement of spe-
cial population groups.
Bio-banks have advantages such as advancement of
scientific knowledge, present and future medical benefits
for the individual, improved pharmaco-genomic under-
standing and commercial benefits through patents. The
major ethical concerns revolve around collection, storage
and management of samples. Human dignity, right to
share benefits, intellectual property rights, access to
personal data, sample sharing by researchers, movement
of samples outside the country, samples from deceased or
non-traceable persons are all issues which has to be care-
fully thought out. Breach of confidentiality and unwanted
information flow can result in anxiety, depression, social
stigma and discrimination. There are also issues of cultural
and social acceptability for taking samples.
The ICMR has issued guidelines for DNA banking in
2006 for primary and secondary use of samples. A draft
DNA Profiling Bill, 2007 is under the consideration of the
Indian Parliament which looks to legalize the collection
and analysis of DNA samples and to create a balance
between the constitutional rights of an individual and the
public interest along with accountability and transparency
in the practice of DNA collection and testing. It will be
essential to establish standards for laboratories, staff quali-
fications, training, proficiency testing, collection of body
substances, custody trail from collection to reporting and
a data Bank with policies of use and access to information
therein, its retention and deletion. Thus genetic technol-
ogy faces ethical challenges in the clinical, social, eco-
nomic, scientific, legal and political domains.
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